Literature DB >> 10412011

Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA.

K Yasojima1, E G McGeer, P L McGeer.   

Abstract

We measured the relative levels of exon 10 containing and exon 10 deleted tau mRNAs in multiple areas of Alzheimer disease (AD) and normal brain. Compared with normal brain, we found a 3.4-fold upregulation of exon 10 plus and a 1.9-fold downregulation of exon 10 minus mRNAs in areas of AD brain with a heavy burden of neurofibrillary tangles. These data suggest that tangle formation in AD is initially determined by transcriptional factors and is not exclusively caused by post-translational events. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412011     DOI: 10.1016/s0006-8993(99)01486-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 2.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

3.  Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.

Authors:  Jianhua Shi; Wei Qian; Xiaomin Yin; Khalid Iqbal; Inge Grundke-Iqbal; Xiaosong Gu; Fei Ding; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

4.  Hsp70 alters tau function and aggregation in an isoform specific manner.

Authors:  Kellen Voss; Benjamin Combs; Kristina R Patterson; Lester I Binder; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

5.  Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.

Authors:  Jerzy Wegiel; Wojciech Kaczmarski; Madhabi Barua; Izabela Kuchna; Krzysztof Nowicki; Kuo-Chiang Wang; Jarek Wegiel; Shuang Ma Yang; Janusz Frackowiak; Bozena Mazur-Kolecka; Wayne P Silverman; Barry Reisberg; Isabel Monteiro; Mony de Leon; Thomas Wisniewski; Arthur Dalton; Florence Lai; Yu-Wen Hwang; Tatyana Adayev; Fei Liu; Khalid Iqbal; Inge-Grundke Iqbal; Cheng-Xin Gong
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

6.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

7.  Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.

Authors:  Wen-Lin An; Richard F Cowburn; Lin Li; Heiko Braak; Irina Alafuzoff; Khalid Iqbal; Inge-Grundke Iqbal; Bengt Winblad; Jin-Jing Pei
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 8.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

9.  Monitoring tau-tubulin interactions utilizing second harmonic generation in living neurons.

Authors:  William H Stoothoff; Brian J Bacskai; Bradley T Hyman
Journal:  J Biomed Opt       Date:  2008 Nov-Dec       Impact factor: 3.170

Review 10.  Regulation of alternative splicing of tau exon 10.

Authors:  Wei Qian; Fei Liu
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.